Levels of serum nerve growth factor in schizophrenia

J. R. Perez-Polo, P. Dy, K. Westlund, K. Hall, K. Livingston

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

There is a significant decrease in the relative levels of NGF activity and NGF antigen in sera from schizophrenic patients when compared to controls. Another significant finding is the different ratios of active NGF to total NGF found in sera from schizophrenic patients. In both schizophrenic males and females there is a significant increase in the NGF activity detected as active relative to the total NGF present. This may be due to differences in the structure of the NGF species present which would be reflected in its ability to dissociate, or it may be due to other components in the sera from schizophrenic patients which would affect dissociation of the complex. Since it is clear that there is an overall depression of NGF levels, it is likely that there are less NGF molecules present. In order to establish this premise it will be necessary to carry out RIA of sera using antibodies directed against human NGF. If further studies of NGF levels in sera from schizophrenic patients confirm these findings, it may be that administration of human NGF could prove to have therapeutic value as Wise. suggested by Stein and wise.

Original languageEnglish (US)
Pages (from-to)311-321
Number of pages11
JournalBirth Defects: Original Article Series
Volume14
Issue number5
StatePublished - 1978
Externally publishedYes

Fingerprint

Nerve Growth Factor
Schizophrenia
Serum
Aptitude
Antigens

ASJC Scopus subject areas

  • Genetics(clinical)
  • Developmental Biology

Cite this

Perez-Polo, J. R., Dy, P., Westlund, K., Hall, K., & Livingston, K. (1978). Levels of serum nerve growth factor in schizophrenia. Birth Defects: Original Article Series, 14(5), 311-321.

Levels of serum nerve growth factor in schizophrenia. / Perez-Polo, J. R.; Dy, P.; Westlund, K.; Hall, K.; Livingston, K.

In: Birth Defects: Original Article Series, Vol. 14, No. 5, 1978, p. 311-321.

Research output: Contribution to journalArticle

Perez-Polo, JR, Dy, P, Westlund, K, Hall, K & Livingston, K 1978, 'Levels of serum nerve growth factor in schizophrenia', Birth Defects: Original Article Series, vol. 14, no. 5, pp. 311-321.
Perez-Polo JR, Dy P, Westlund K, Hall K, Livingston K. Levels of serum nerve growth factor in schizophrenia. Birth Defects: Original Article Series. 1978;14(5):311-321.
Perez-Polo, J. R. ; Dy, P. ; Westlund, K. ; Hall, K. ; Livingston, K. / Levels of serum nerve growth factor in schizophrenia. In: Birth Defects: Original Article Series. 1978 ; Vol. 14, No. 5. pp. 311-321.
@article{b73e416fb32e4fcea4d9d29efc4b1430,
title = "Levels of serum nerve growth factor in schizophrenia",
abstract = "There is a significant decrease in the relative levels of NGF activity and NGF antigen in sera from schizophrenic patients when compared to controls. Another significant finding is the different ratios of active NGF to total NGF found in sera from schizophrenic patients. In both schizophrenic males and females there is a significant increase in the NGF activity detected as active relative to the total NGF present. This may be due to differences in the structure of the NGF species present which would be reflected in its ability to dissociate, or it may be due to other components in the sera from schizophrenic patients which would affect dissociation of the complex. Since it is clear that there is an overall depression of NGF levels, it is likely that there are less NGF molecules present. In order to establish this premise it will be necessary to carry out RIA of sera using antibodies directed against human NGF. If further studies of NGF levels in sera from schizophrenic patients confirm these findings, it may be that administration of human NGF could prove to have therapeutic value as Wise. suggested by Stein and wise.",
author = "Perez-Polo, {J. R.} and P. Dy and K. Westlund and K. Hall and K. Livingston",
year = "1978",
language = "English (US)",
volume = "14",
pages = "311--321",
journal = "Birth Defects: Original Article Series",
issn = "0547-6844",
publisher = "March of Dimes Birth Defects Foundation",
number = "5",

}

TY - JOUR

T1 - Levels of serum nerve growth factor in schizophrenia

AU - Perez-Polo, J. R.

AU - Dy, P.

AU - Westlund, K.

AU - Hall, K.

AU - Livingston, K.

PY - 1978

Y1 - 1978

N2 - There is a significant decrease in the relative levels of NGF activity and NGF antigen in sera from schizophrenic patients when compared to controls. Another significant finding is the different ratios of active NGF to total NGF found in sera from schizophrenic patients. In both schizophrenic males and females there is a significant increase in the NGF activity detected as active relative to the total NGF present. This may be due to differences in the structure of the NGF species present which would be reflected in its ability to dissociate, or it may be due to other components in the sera from schizophrenic patients which would affect dissociation of the complex. Since it is clear that there is an overall depression of NGF levels, it is likely that there are less NGF molecules present. In order to establish this premise it will be necessary to carry out RIA of sera using antibodies directed against human NGF. If further studies of NGF levels in sera from schizophrenic patients confirm these findings, it may be that administration of human NGF could prove to have therapeutic value as Wise. suggested by Stein and wise.

AB - There is a significant decrease in the relative levels of NGF activity and NGF antigen in sera from schizophrenic patients when compared to controls. Another significant finding is the different ratios of active NGF to total NGF found in sera from schizophrenic patients. In both schizophrenic males and females there is a significant increase in the NGF activity detected as active relative to the total NGF present. This may be due to differences in the structure of the NGF species present which would be reflected in its ability to dissociate, or it may be due to other components in the sera from schizophrenic patients which would affect dissociation of the complex. Since it is clear that there is an overall depression of NGF levels, it is likely that there are less NGF molecules present. In order to establish this premise it will be necessary to carry out RIA of sera using antibodies directed against human NGF. If further studies of NGF levels in sera from schizophrenic patients confirm these findings, it may be that administration of human NGF could prove to have therapeutic value as Wise. suggested by Stein and wise.

UR - http://www.scopus.com/inward/record.url?scp=0018086639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018086639&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 311

EP - 321

JO - Birth Defects: Original Article Series

JF - Birth Defects: Original Article Series

SN - 0547-6844

IS - 5

ER -